Ran Xu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Urology top 5%
Papers in
-
- Extracellular vesicles in disease 7
- Circular RNAs in diseases 5
- Surgery 23
- Bladder and Urothelial Cancer Treatments 15
- Urinary and Genital Oncology Studies 5
- Co-authors
- Xiaokun Zhao (35 shared papers)Xuan Zhu (19 shared papers)Zhaohui Zhong (20 shared papers)Hui Xie (7 shared papers)Zhen‐Xing Wang (7 shared papers)Chun‐Yuan Chen (4 shared papers)Shan‐Shan Rao (4 shared papers)Jia Cao (4 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (6 papers)Scientific Reports (5 papers)PLoS ONE (4 papers)Oncotarget (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ran Xu
171 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 175
- Cancer Research 558
- Urology 108
- Molecular Biology 1.2k
- Rehabilitation 91
- Genetics 121
Countries citing papers authored by Ran Xu
This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).
Fields of papers citing papers by Ran Xu
This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 306 | |
| 2 | 2020 | 170 | |
| 3 | 2018 | 133 | |
| 4 | 2018 | 126 | |
| 5 | 2021 | 125 | |
| 6 | 2019 | 117 | |
| 7 | 2018 | 75 | |
| 8 | 2020 | 64 | |
| 9 | 2019 | 58 | |
| 10 | 2020 | 57 | |
| 11 | 2023 | 54 | |
| 12 | 2010 | 54 | |
| 13 | 2017 | 53 | |
| 14 | 2017 | 51 | |
| 15 | 2019 | 50 | |
| 16 | 2023 | 48 | |
| 17 | 2016 | 47 | |
| 18 | 2017 | 47 | |
| 19 | 2015 | 45 | |
| 20 | 2022 | 44 |
About Ran Xu
Ran Xu is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Cancer Research, having authored 197 papers that have together received 3.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (7 papers), Congenital Heart Disease Studies (5 papers), Circular RNAs in diseases (5 papers), Kidney Stones and Urolithiasis Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (558 citations), Urology (108 citations), Molecular Biology (1.2k citations), Rehabilitation (91 citations) and Genetics (121 citations). Ran Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiaokun Zhao, Xuan Zhu, Zhaohui Zhong, Hui Xie, Zhen‐Xing Wang, Chun‐Yuan Chen, Shan‐Shan Rao, Jia Cao, Xu Chen and Jing Zhu. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Scientific Reports, PLoS ONE, Oncotarget and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.